Serological response to nifurtimox in adult patients with chronic Chagas disease: An observational comparative study in Argentina

Nifurtimox is indicated in Chagas disease but determining its effectiveness in chronic disease is hindered by the length of time needed to demonstrate negative serological conversion. We manually reviewed long-term follow-up data from hospital records of patients with chronic Chagas disease (N = 1,4...

Descripción completa

Detalles Bibliográficos
Autores principales: Vizcaya, David, Grossmann, Ulrike, Kleinjung, Frank, Zhang, Ruiping, Suzart-Woischnik, Kiliana, Seu, Sandra, Ramirez, Teresa, Colmegna, Leylen, Ledesma, Oscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489720/
https://www.ncbi.nlm.nih.gov/pubmed/34606501
http://dx.doi.org/10.1371/journal.pntd.0009801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489720/
https://www.ncbi.nlm.nih.gov/pubmed/34606501
http://dx.doi.org/10.1371/journal.pntd.0009801

Ejemplares similares